Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation

SIMPLE SUMMARY: The clinical success of immunotherapies using immune checkpoint blockers deployed in melanoma strongly supports that the immune system can efficiently control tumor development in the long term. Yet, despite unprecedented successes, many patients still experienced relapse or failed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa Cuevas, Eleonora, Saas, Philippe, Aspord, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136655/
https://www.ncbi.nlm.nih.gov/pubmed/37190135
http://dx.doi.org/10.3390/cancers15082206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136655/
https://www.ncbi.nlm.nih.gov/pubmed/37190135
http://dx.doi.org/10.3390/cancers15082206

Ejemplares similares